Fosun Pharma is spending 1.4 billion Chinese yuan ($200 million) to take on a 53% stake in Green Valley Pharmaceuticals and ...

The Alzheimer's Drug Discovery Foundation (ADDF) today announced two new members to its Board of Governors: Gavin Cook, ...

If you have a loved one with Alzheimer’s disease, you may have read about a newly approved drug. And you may have heard that the drug has caused some controversy. So, what’s really going on? In early ...

COULD HELP OTHERS. TERRY BECKER IS A RETIRED FIFTH GRADE TEACHER, BUT THE YOUNG PEOPLE GETTING HIS ATTENTION THESE DAYS ARE HIS FOUR GRANDDAUGHTERS. OUR DAUGHTER AND HER HUSBAND, AND TWO GIRLS. THEY ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. One of neurologist Anelyssa D’Abreu’s least ...

In 2021, the fda approved a treatment that claims to stop Alzheimer's at the source, removing the plaques in the brain long thought to cause the symptoms of the disease. But, as is often the case, ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

After covering the Alzheimer’s space through every high and low, BioSpace’s Annalee Armstrong welcomes back Roche for the 2026 Alzheimer’s Renaissance.

The results mark a setback for the hypothesis that drugs like semaglutide could provide a neuroprotective effect for patients ...